• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多特征和终点的机器学习预测药物性肝损伤(DILI)。

Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints.

机构信息

Department of Burns, Changhai Hospital, Second Military Medical University, Shanghai, China.

The Centre for Big Data Research in Burns and Trauma, Fuzhou University, Fujian Province, China.

出版信息

Biomed Res Int. 2020 May 19;2020:4795140. doi: 10.1155/2020/4795140. eCollection 2020.

DOI:10.1155/2020/4795140
PMID:32509859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7254069/
Abstract

Drug discovery is a costly process which usually takes more than 10 years and billions of dollars for one successful drug to enter the market. Despite all the safety tests, drugs may still cause adverse reactions and be restricted in use or even withdrawn from the market. Drug-induced liver injury (DILI) is one of the major adverse drug reactions, and computational models may be used to predict and reduce it. To assess the computational prediction performance of DILI, we curated DILI endpoints from three databases and prepared drug features including chemical descriptors, therapeutic classifications, gene expressions, and binding proteins. We trained machine-learning models to predict the various DILI endpoints using different drug features. Using the optimal feature sets, the top-performing models obtained areas under the receiver operating characteristic curve (AUC) around 0.8 for some DILI endpoints. We found that some features, including therapeutic classifications and proteins, have good prediction performance towards DILI. We also discovered that the severity of DILI endpoints as well as the selection of negative samples may significantly affect the prediction results. Overall, our study provided a comprehensive collection, curation, and prediction of DILI endpoints using various drug features, which may help the drug researchers to better understand and prevent DILI during the drug discovery process.

摘要

药物发现是一个成本高昂的过程,通常需要超过 10 年的时间和数十亿美元的资金,才能使一种成功的药物进入市场。尽管进行了所有的安全测试,药物仍然可能引起不良反应,并限制使用,甚至从市场上撤回。药物性肝损伤 (DILI) 是主要的药物不良反应之一,可以使用计算模型来预测和减少它。为了评估 DILI 的计算预测性能,我们从三个数据库中整理了 DILI 终点,并准备了药物特征,包括化学描述符、治疗分类、基因表达和结合蛋白。我们使用不同的药物特征训练机器学习模型来预测各种 DILI 终点。使用最佳特征集,针对某些 DILI 终点,表现最佳的模型获得了接近 0.8 的接收器操作特征曲线 (AUC) 下面积。我们发现,一些特征,包括治疗分类和蛋白质,对 DILI 具有良好的预测性能。我们还发现,DILI 终点的严重程度以及阴性样本的选择可能会显著影响预测结果。总的来说,我们的研究使用各种药物特征对 DILI 终点进行了全面的收集、整理和预测,这可能有助于药物研究人员在药物发现过程中更好地理解和预防 DILI。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/7d4f118d9267/BMRI2020-4795140.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/7f8829fba73e/BMRI2020-4795140.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/696f3228a3d4/BMRI2020-4795140.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/7d4f118d9267/BMRI2020-4795140.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/7f8829fba73e/BMRI2020-4795140.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/696f3228a3d4/BMRI2020-4795140.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6328/7254069/7d4f118d9267/BMRI2020-4795140.003.jpg

相似文献

1
Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints.基于多特征和终点的机器学习预测药物性肝损伤(DILI)。
Biomed Res Int. 2020 May 19;2020:4795140. doi: 10.1155/2020/4795140. eCollection 2020.
2
Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).比较用于预测药物性肝损伤(DILI)的机器学习算法。
Mol Pharm. 2020 Jul 6;17(7):2628-2637. doi: 10.1021/acs.molpharmaceut.0c00326. Epub 2020 Jun 8.
3
Gene Expression Data Based Deep Learning Model for Accurate Prediction of Drug-Induced Liver Injury in Advance.基于基因表达数据的深度学习模型可提前准确预测药物性肝损伤
J Chem Inf Model. 2019 Jul 22;59(7):3240-3250. doi: 10.1021/acs.jcim.9b00143. Epub 2019 Jun 28.
4
Prediction of Drug-Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches.药物性肝损伤的预测:从分子理化性质和支架结构到机器学习方法。
Chem Biol Drug Des. 2024 Aug;104(2):e14607. doi: 10.1111/cbdd.14607.
5
An In Silico Model for Predicting Drug-Induced Hepatotoxicity.一种用于预测药物性肝毒性的计算机模型。
Int J Mol Sci. 2019 Apr 17;20(8):1897. doi: 10.3390/ijms20081897.
6
In-silico approach for drug induced liver injury prediction: Recent advances.计算机辅助药物性肝损伤预测方法:最新进展。
Toxicol Lett. 2018 Oct 1;295:288-295. doi: 10.1016/j.toxlet.2018.06.1216. Epub 2018 Jul 5.
7
Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.利用大型 FDA 批准药物集开发用于预测人类药物性肝损伤的决策森林模型。
Sci Rep. 2017 Dec 11;7(1):17311. doi: 10.1038/s41598-017-17701-7.
8
An ensemble learning approach for modeling the systems biology of drug-induced injury.一种用于药物诱导损伤系统生物学建模的集成学习方法。
Biol Direct. 2021 Jan 12;16(1):5. doi: 10.1186/s13062-020-00288-x.
9
Ensemble Models Based on QuBiLS-MAS Features and Shallow Learning for the Prediction of Drug-Induced Liver Toxicity: Improving Deep Learning and Traditional Approaches.基于 QuBiLS-MAS 特征和浅层学习的药物性肝毒性预测的集成模型:改进深度学习和传统方法。
Chem Res Toxicol. 2020 Jul 20;33(7):1855-1873. doi: 10.1021/acs.chemrestox.0c00030. Epub 2020 May 14.
10
In Silico Prediction of Drug-Induced Liver Injury Based on Ensemble Classifier Method.基于集成分类器方法的药物性肝损伤的计算机预测。
Int J Mol Sci. 2019 Aug 22;20(17):4106. doi: 10.3390/ijms20174106.

引用本文的文献

1
Role of artificial intelligence in revolutionizing drug discovery.人工智能在变革药物研发中的作用。
Fundam Res. 2024 May 9;5(3):1273-1287. doi: 10.1016/j.fmre.2024.04.021. eCollection 2025 May.
2
Predicting Liver-Related In Vitro Endpoints with Machine Learning to Support Early Detection of Drug-Induced Liver Injury.利用机器学习预测肝脏相关体外终点以支持药物性肝损伤的早期检测
Chem Res Toxicol. 2025 Apr 21;38(4):656-671. doi: 10.1021/acs.chemrestox.4c00453. Epub 2025 Mar 10.
3
Development of a Novel In Silico Classification Model to Assess Reactive Metabolite Formation in the Cysteine Trapping Assay and Investigation of Important Substructures.

本文引用的文献

1
Development of Prediction Models for Drug-Induced Cholestasis, Cirrhosis, Hepatitis, and Steatosis Based on Drug and Drug Metabolite Structures.基于药物和药物代谢物结构的药物性胆汁淤积、肝硬化、肝炎和脂肪变性预测模型的开发。
Front Pharmacol. 2020 Feb 14;11:67. doi: 10.3389/fphar.2020.00067. eCollection 2020.
2
Hepatotoxicity Modeling Using Counter-Propagation Artificial Neural Networks: Handling an Imbalanced Classification Problem.使用对向传播人工神经网络进行肝毒性建模:处理不平衡分类问题。
Molecules. 2020 Jan 23;25(3):481. doi: 10.3390/molecules25030481.
3
An In Silico Model for Predicting Drug-Induced Hepatotoxicity.
新型计算机分类模型的建立用于评估半胱氨酸捕集试验中反应代谢产物的形成,并研究重要的亚结构。
Biomolecules. 2024 Apr 30;14(5):535. doi: 10.3390/biom14050535.
4
Risk control drives risk assessment and risk review: A cause and effect model of pharmaceutical drug recall on patient safety.风险控制驱动风险评估与风险审查:药品召回对患者安全影响的因果模型
J Med Access. 2023 May 11;7:27550834231170075. doi: 10.1177/27550834231170075. eCollection 2023 Jan-Dec.
5
Towards Decoding Hepatotoxicity of Approved Drugs through Navigation of Multiverse and Consensus Chemical Spaces.通过多元宇宙和共识化学空间的导航来解码已批准药物的肝毒性。
Biomolecules. 2023 Jan 14;13(1):176. doi: 10.3390/biom13010176.
6
Applications of In Silico Models to Predict Drug-Induced Liver Injury.用于预测药物性肝损伤的计算机模拟模型的应用
Toxics. 2022 Dec 14;10(12):788. doi: 10.3390/toxics10120788.
7
Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury.小分子激酶抑制剂相关药物性肝损伤的特征研究
Front Pharmacol. 2022 Apr 21;13:838397. doi: 10.3389/fphar.2022.838397. eCollection 2022.
8
Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors.利用多种预测因素通过机器学习预测药物性肝损伤
Front Pharmacol. 2021 Aug 18;12:648805. doi: 10.3389/fphar.2021.648805. eCollection 2021.
一种用于预测药物性肝毒性的计算机模型。
Int J Mol Sci. 2019 Apr 17;20(8):1897. doi: 10.3390/ijms20081897.
4
DrugBank 5.0: a major update to the DrugBank database for 2018.DrugBank 5.0:2018 年 DrugBank 数据库的重大更新。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037.
5
Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats.支链氨基酸代谢受损可能是新生期睾酮处理雌性大鼠非酒精性脂肪性肝病样病变的基础。
Sci Rep. 2017 Oct 13;7(1):13167. doi: 10.1038/s41598-017-13451-8.
6
In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports.基于药物不良反应报告的药物性肝损伤的计算机预测。
Toxicol Sci. 2017 Aug 1;158(2):391-400. doi: 10.1093/toxsci/kfx099.
7
Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters-An in Silico Modeling Approach.借助肝脏转运体预测药物性胆汁淤积——一种计算机模拟建模方法
J Chem Inf Model. 2017 Mar 27;57(3):608-615. doi: 10.1021/acs.jcim.6b00518. Epub 2017 Mar 8.
8
Current limitations and future opportunities for prediction of DILI from in vitro.从体外预测药物性肝损伤的当前局限性和未来机遇。
Arch Toxicol. 2017 Jan;91(1):131-142. doi: 10.1007/s00204-016-1874-9. Epub 2016 Oct 20.
9
Molecular Docking for Identification of Potential Targets for Drug Repurposing.用于药物重新利用潜在靶点鉴定的分子对接
Curr Top Med Chem. 2016;16(30):3636-3645. doi: 10.2174/1568026616666160530181149.
10
A Model to predict severity of drug-induced liver injury in humans.用于预测药物性肝损伤严重程度的模型。
Hepatology. 2016 Sep;64(3):931-40. doi: 10.1002/hep.28678. Epub 2016 Jul 27.